A few things I think caused this.
Traders bought into the
A few things I think caused this.
Traders bought into the news and dumped
It's the OTC
There are people who disdain Gerald and will try to make him look bad even if they lose money on a flip.
Also, I don't think enough of the general public know or understand what TODOS is.
That'll all change and things may be different on the big board once we uplist.
But there's also those who will short it with passion just because of Gerald.
I think Gerald has done a bang up job and will get both Todos & AMBS across the proverbial "goal line".
After today, I don't see an issue with the science so everything else will take care of itself.
Once in phase 2/3 I see partnership or a full buyout of the COVID-19 arm of the business.
Package Tollovid, Tollovir & TolloTest up and make a fortune with royalties or whatever deal he makes and move the rest of Todos forward.
Once people understand that story plus the amount of money being generated for COVID testing alone , we should see a hockey stick type of rise in the pps.
That's when Gerald & Co. will flip the switch and the uplist will happen overnight
Excellent day for us & Science!
1
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding the Textile Recycling Market Growth The global textile recycling market is experiencing significant transformation fueled by a growing emphasis on sustainability and environmental awareness. With a projected value reaching approximately $7.26 billion, and an expected annual growth rate of 4.9%, the industry reflects changing consumer preferences and global...
Continue Reading
Mobile Infrastructure Corporation Closes Major Financing Round Mobile Infrastructure Corporation (NASDAQ: BEEP) has successfully completed a significant $100 million Asset-Backed Securitization (ABS) focused on enhancing its financial structure and opening avenues for future growth. This landmark achievement is a testament to the forward-thinking strategies and the robust...
Continue Reading
Global Kiosk Market Overview As we delve into the dynamic landscape of the kiosk market, projections indicate an impressive growth trajectory. The global kiosk market is set to expand significantly, with expectations to reach a remarkable USD 62.2 billion by the end of the forecast period. The anticipated compound annual growth rate (CAGR) of 12.74% from 2024 to 2031...
Continue Reading
Wallbridge Mining Launches Phase 2 Drilling at Martiniere Wallbridge Mining Company Limited (TSX: WM, OTCQB: WLBMF) is excited to announce that it has commenced its second phase of drilling at the fully owned Martiniere gold project. This new drilling campaign aims to build on the positive results from its Phase 1 drilling campaign. Continuing Exploration Efforts The...
Continue Reading
Spirovant Sciences Launches Groundbreaking Gene Therapy Trial Spirovant Sciences, a pioneering clinical-stage gene therapy company, has taken a significant step forward in the battle against cystic fibrosis with the administration of the first dose in their SAAVe Phase 1/2 clinical trial of SP-101 combined with a unique augmenter. The Innovative SP-101 Treatment SP-101 is...
Continue Reading